The PolyPeptide Group is a privately-held Contract Development & Manufacturing Organization (CDMO) who focuses on proprietary and generic GMP-grade peptides for the diagnostic, cosmetic, pharmaceutical and biotechnological market. As one of the world’s largest independent contract manufacturers of therapeutic peptides, the Group manufactures over one third of all approved peptide drug substances and accounts for ~30 % of the sales of outsourced peptide therapeutics worldwide.
With six GMP facilities worldwide, located in Belgium, France, India, Sweden and the USA, and an exclusive focus on pharmaceutical peptide manufacture, PolyPeptide Group offers its customers an unprecedented long-term security of supply. The same level of expertise, technology, quality and innovation is guaranteed across the globe, regardless of the site of manufacture. Whether your need is gram quantities or 100’s of kilograms of peptide or peptide-like API’s, PolyPeptide’s experience, focus and established regulatory track record offers Global Support for a Quality Solution.
For more information: polypeptide.com